Discover how a Pan-cancer biomarker platform accelerates research by cross-comparing signals across multiple cancers, revealing shared targets and unique patterns.
This approach helps clinicians identify universal and cancer-specific biomarkers, guiding precision therapies and advancing personalized medicine across diverse tumor types.